Home › Myriad Genetics (MYGN) Forecasted to Post Q1 2017 Earnings of $0.45 Per Share
 

Keywords :   


Myriad Genetics (MYGN) Forecasted to Post Q1 2017 Earnings of $0.45 Per Share

2015-11-07 07:41:57| Biotech - Topix.net

Investment analysts at Jefferies Group cut their Q1 2017 earnings per share estimates for shares of Myriad Genetics in a research note issued on Wednesday, according to Zacks Investment Research . Jefferies Group analyst B. Couillard now forecasts that the firm will earn $0.45 per share for the quarter, down from their prior estimate of $0.46.

Tags: post share earnings genetics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »